Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Historical Holders from Q3 2024 to Q3 2025

Symbol
TRAW on Nasdaq
Type / Class
Equity / Common Stock, par value $.01 per share
Shares outstanding
7,035,714
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
1,304,595
Holdings value
$2,413,244
% of all portfolios
0%
Number of holders
18
Number of buys
9
Number of sells
-5
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
PERCEPTIVE ADVISORS LLC 9.99% 0% $1,641,628 +$632,468 886,887 +63% Perceptive Advisors LLC 30 Sep 2025
ORBIMED ADVISORS LLC 19.9% $1,164,061 760,824 ORBIMED ADVISORS LLC 31 Dec 2024
Squadron Capital Management LLC 8.4% +40% $1,093,941 +$315,594 591,000 +41% Squadron Capital Management LLC 30 Sep 2025
Ikarian Capital, LLC 9.99% 0% $901,938 +$298,728 589,502 +50% Ikarian Capital, LLC 31 Mar 2025
Ayrton Capital LLC 9.9% $617,584 403,650 Ayrton Capital LLC 31 Dec 2024
Adage Capital Management, L.P. 4.67% -26% $610,830 330,000 0% Adage Capital Management, L.P. 30 Sep 2025
Alyeska Investment Group, L.P. 9.9% $462,446 302,252 Alyeska Investment Group, L.P. 31 Dec 2024

Institutional Holders of Traws Pharma, Inc. - Common Stock, par value $.01 per share (TRAW)

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q3 1,304,595 $2,413,244 +$101,966 $1.85 18
2025 Q2 1,263,487 $1,869,962 -$1,075,287 $1.48 19
2025 Q1 1,732,309 $3,984,315 +$1,207,345 $2.3 18
2024 Q4 1,141,975 $10,140,752 +$4,400,867 $8.88 17
2024 Q3 646,356 $3,800,574 +$3,742,033 $5.88 10